lorazepam has been researched along with clonidine in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (12.00) | 18.7374 |
1990's | 5 (20.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Crammer, JL; Keshavan, MS | 1 |
Cerri, C; Cocco, E; Rovati, L | 1 |
Friedman, LS; Mayo-Smith, MF; Saitz, R | 1 |
de Angelis, L | 1 |
Brugioni, L; Graziina, A; Luciani, A; Serra, L | 1 |
Hiestand, DC; Howie, MB; Jopling, MW; Kelly, WB; McSweeney, TD; Romanelli, VA | 1 |
Hudson, RJ; Peterson, MD; Thomson, IR | 1 |
Baruch, EM; Deerfield, LJ; Rosenberg, MH | 1 |
Amabile, CM; Couillard, D; Norcross, ED; Simpson, KN; Stanley, KM; Worrall, CL | 1 |
Lunsford, SL; Miller, JG; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL | 1 |
Barnes, BJ; Lunsford, SL; Miller, JG; Moeller, KE; Simpson, KN; Spencer, AP; Stanley, KM; Worrall, CL | 1 |
Caballero, J; Gonzalez-Blanco, M | 1 |
Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR | 1 |
da Silva, PS; Passos, RM; Waisberg, DR | 1 |
Cai, Y; Chen, K; Chen, Y; Lu, Z; Pan, SM; Xin, YC | 1 |
2 review(s) available for lorazepam and clonidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Bradycardia; Clonidine; Conscious Sedation; Critical Illness; Dexmedetomidine; Humans; Lorazepam; Midazolam; Propofol; Randomized Controlled Trials as Topic; Respiration, Artificial; Selection Bias; Time Factors | 2015 |
2 trial(s) available for lorazepam and clonidine
Article | Year |
---|---|
Effect of oral clonidine premedication on anesthetic requirement, hormonal response, hemodynamics, and recovery in coronary artery bypass graft surgery patients.
Topics: Adrenergic alpha-Agonists; Anesthesia; Anesthesia Recovery Period; Clonidine; Coronary Artery Bypass; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Hormones; Humans; Lorazepam; Male; Middle Aged; Preanesthetic Medication; Sufentanil | 1996 |
A comparison of clonidine with conventional preanesthetic medication in patients undergoing coronary artery bypass grafting.
Topics: Adrenergic alpha-Agonists; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Clonidine; Coronary Artery Bypass; Double-Blind Method; Electroencephalography; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Morphine; Preanesthetic Medication; Sufentanil; Sympatholytics | 1998 |
21 other study(ies) available for lorazepam and clonidine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Clonidine in benzodiazepine withdrawal.
Topics: Adult; Clonidine; Humans; Lorazepam; Male; Substance Withdrawal Syndrome | 1985 |
Propranolol and clonidine in detoxification.
Topics: Clonidine; Humans; Lorazepam; Methadone; Opioid-Related Disorders; Propranolol; Psychomotor Agitation | 1988 |
Alcohol withdrawal: a nationwide survey of inpatient treatment practices.
Topics: Adrenergic beta-Antagonists; Alcoholism; Barbiturates; Benzodiazepines; Chlordiazepoxide; Clonidine; Data Collection; Diazepam; Drug Administration Schedule; Hypnotics and Sedatives; Inpatients; Lorazepam; Oxazepam; Phenytoin; Substance Withdrawal Syndrome | 1995 |
Effects of valproate and lorazepam on experimental anxiety: tolerance, withdrawal, and role of clonidine.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Clonidine; Drug Tolerance; Female; Injections, Intraperitoneal; Lorazepam; Mice; Substance Withdrawal Syndrome; Valproic Acid | 1995 |
Sino-atrial and atrio-ventricular node dysfunction in a case of tizanidine overdose.
Topics: Adult; Atrioventricular Node; Clonidine; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Lorazepam; Muscle Relaxants, Central; Sinoatrial Node; Suicide, Attempted | 1995 |
Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Clonazepam; Clonidine; Delirium; Hospitalization; Humans; Lorazepam; Male; Phenobarbital; Practice Guidelines as Topic; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome | 2003 |
Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.
Topics: Adolescent; Adult; Aged; Alcohol-Related Disorders; Clonidine; Ethanol; Female; Haloperidol; Humans; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Postoperative Complications; Practice Guidelines as Topic; Prospective Studies; Restraint, Physical; Retrospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Surgical Procedures, Operative | 2003 |
Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Female; Haloperidol; Hospitals, Teaching; Humans; Internal Medicine; Length of Stay; Lorazepam; Male; Middle Aged; Pilot Projects; Practice Guidelines as Topic; Restraint, Physical; Retrospective Studies; Treatment Outcome | 2005 |
Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Clonidine; Ethanol; Evidence-Based Medicine; Haloperidol; Humans; Lorazepam; Practice Guidelines as Topic; Substance Withdrawal Syndrome | 2006 |
Treatment of postpartum depression with psychotic features in a patient with tropical spastic paraparesis.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benztropine; Clonidine; Depression, Postpartum; Female; Haiti; Haloperidol; Humans; Lorazepam; Paraparesis, Tropical Spastic; Parasympatholytics; Sertraline | 2008 |
A nonopioid procedure for outpatient opioid detoxification.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult | 2011 |
Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Chloral Hydrate; Clonidine; Fentanyl; Humans; Hypnotics and Sedatives; Infant; Intensive Care, Neonatal; Lorazepam; Male; Methadone; Midazolam; Pneumonia; Respiratory Insufficiency; Substance Withdrawal Syndrome | 2011 |